Skip to main content
Mark Silberman, MD, Pathology, Austin, TX

MarkSilbermanMD

Pathology Austin, TX

Hematopathology, Anatomic Pathology, Clinical Pathology

Clinical Pathology Associates Laboratory Director Clinical Pathology Laboratories Austin, TX

Dr. Silberman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Silberman's full profile

Already have an account?

  • Office

    3445 Executive Center Dr
    Ste 250
    Austin, TX 78731
    Phone+1 512-579-4000
    Fax+1 512-439-2814

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematopathology, 1997 - 1998
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 1992 - 1997
  • Pennsylvania Hospital of the University of Pennsylvania Health System
    Pennsylvania Hospital of the University of Pennsylvania Health SystemInternship, Internal Medicine, 1991 - 1992
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1991

Certifications & Licensure

  • NM State Medical License
    NM State Medical License 2018 - 2027
  • FL State Medical License
    FL State Medical License 2011 - 2026
  • NY State Medical License
    NY State Medical License 2011 - 2026
  • RI State Medical License
    RI State Medical License 2013 - 2026
  • VA State Medical License
    VA State Medical License 2011 - 2026
  • GA State Medical License
    GA State Medical License 2017 - 2025
  • LA State Medical License
    LA State Medical License 2019 - 2025
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Hematology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Breakthrough COVID-19 Cases Occur in 7.5% of Vaccinated Texas Participants, According to UTHealth Houston Survey; Subgroups at Higher Risk Identified
    Breakthrough COVID-19 Cases Occur in 7.5% of Vaccinated Texas Participants, According to UTHealth Houston Survey; Subgroups at Higher Risk IdentifiedFebruary 2nd, 2023
  • Toxic Metals in Baby Food: Researchers Find ‘Concerning’ Gaps in U.S. Regulations
    Toxic Metals in Baby Food: Researchers Find ‘Concerning’ Gaps in U.S. RegulationsFebruary 1st, 2023
  • COVID-19 Antibodies Can Last up to 500 Days After Infection
    COVID-19 Antibodies Can Last up to 500 Days After InfectionMay 31st, 2022
  • Join now to see all

Other Languages

  • Spanish